Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

13.24
-0.2700-2.00%
Post-market: 13.250.0100+0.08%19:43 EDT
Volume:1.89M
Turnover:25.08M
Market Cap:1.83B
PE:-3.67
High:13.49
Open:13.41
Low:13.12
Close:13.51
52wk High:15.40
52wk Low:4.40
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.94
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:21.61
PE(LYR):-4.30

Loading ...

Earnings Flash (CMPS) Compass Pathways Posts Q2 Loss $1.88 a Share, vs. FactSet Est of $0.33 Loss

MT Newswires Live
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate

Benzinga Earnings
·
Aug 05

Compass Pathways Q2 EPS USD -1.88

THOMSON REUTERS
·
Aug 05

Compass Pathways Q2 Operating Expenses USD 52.372 Million

THOMSON REUTERS
·
Aug 05

Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Dow Jones
·
Aug 05

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Compass Pathways to Report Q2, First-half Results, Host Conference Call

Reuters
·
Jul 29

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

THOMSON REUTERS
·
Jul 29

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Reuters
·
Jul 27

Compass Pathways Initiated at Equal-Weight by Wells Fargo

Dow Jones
·
Jul 27

Wells Fargo Initiates COMPASS Pathways at Equalweight

MT Newswires Live
·
Jul 27

Compass Pathways initiated with an Equal Weight at Wells Fargo

TIPRANKS
·
Jul 27

COMPASS Pathways PLC put volume heavy and directionally bearish

TIPRANKS
·
Jul 18

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
Jul 16

Compass Pathways Reports Post-hoc Analysis Showing Comp360 Trial Support Distinct from Psychotherapy

Reuters
·
Jul 16

Should COMP360’s Durable Phase 3 Results and FDA Momentum Require Action From COMPASS Pathways (CMPS) Investors?

Simply Wall St.
·
Jul 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Jul 13

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), COMPASS Pathways (CMPS)

TIPRANKS
·
Jul 11

Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts

TIPRANKS
·
Jul 11